25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

OCC (Orthocell) Stock Analysis
Buy, Hold or Sell?

Let's analyze Orthocell together

I guess you are interested in Orthocell Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Orthocell’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Orthocell’s Price Targets

I'm going to help you getting a better view of Orthocell Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Orthocell Ltd

I send you an email if I find something interesting about Orthocell Ltd.

1. Quick Overview

1.1. Quick analysis of Orthocell (30 sec.)










1.2. What can you expect buying and holding a share of Orthocell? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
A$0.02
Expected worth in 1 year
A$-0.01
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
A$-0.03
Return On Investment
-2.1%

For what price can you sell your share?

Current Price per Share
A$1.27
Expected price per share
A$0.745 - A$1.79
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Orthocell (5 min.)




Live pricePrice per Share (EOD)
A$1.27
Intrinsic Value Per Share
A$-0.19 - A$-0.01
Total Value Per Share
A$-0.17 - A$0.01

2.2. Growth of Orthocell (5 min.)




Is Orthocell growing?

Current yearPrevious yearGrowGrow %
How rich?$2.9m$4m-$1m-35.7%

How much money is Orthocell making?

Current yearPrevious yearGrowGrow %
Making money-$4.7m-$4.1m-$613.9k-13.0%
Net Profit Margin-135.1%-147.3%--

How much money comes from the company's main activities?

2.3. Financial Health of Orthocell (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#680 / 872

Most Revenue
#373 / 872

Most Profit
#409 / 872

Most Efficient
#539 / 872
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Orthocell?

Welcome investor! Orthocell's management wants to use your money to grow the business. In return you get a share of Orthocell.

First you should know what it really means to hold a share of Orthocell. And how you can make/lose money.

Speculation

The Price per Share of Orthocell is A$1.265. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Orthocell.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Orthocell, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.02. Based on the TTM, the Book Value Change Per Share is A$-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is A$-0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Orthocell.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps-0.02-1.5%-0.02-1.5%-0.02-1.3%-0.02-1.6%-0.02-1.6%-0.02-1.3%
Usd Book Value Change Per Share0.00-0.3%0.00-0.3%-0.01-0.8%-0.01-0.9%0.00-0.3%0.000.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-0.3%0.00-0.3%-0.01-0.8%-0.01-0.9%0.00-0.3%0.000.1%
Usd Price Per Share0.23-0.23-0.23-0.24-0.27-0.25-
Price to Earnings Ratio-12.03--12.03--13.63--12.16--12.97--16.00-
Price-to-Total Gains Ratio-53.44--53.44--22.68--30.09--23.67--48.68-
Price to Book Ratio19.06-19.06-13.85-14.29-11.01-15.02-
Price-to-Total Gains Ratio-53.44--53.44--22.68--30.09--23.67--48.68-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.832623
Number of shares1201
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (1201 shares)-5.25-4.02
Gains per Year (1201 shares)-21.00-16.09
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-21-310-16-26
20-42-520-32-42
30-63-730-48-58
40-84-940-64-74
50-105-1150-80-90
60-126-1360-97-106
70-147-1570-113-122
80-168-1780-129-138
90-189-1990-145-154
100-210-2200-161-170

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.012.02.00.0%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%4.06.00.040.0%6.08.00.042.9%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.014.00.0%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%4.06.00.040.0%6.08.00.042.9%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Orthocell Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.007-0.0070%-0.015+132%-0.017+155%-0.005-23%0.002-463%
Book Value Per Share--0.0190.0190%0.025-26%0.028-34%0.048-61%0.035-47%
Current Ratio--4.3364.3360%5.930-27%5.146-16%7.090-39%5.126-15%
Debt To Asset Ratio--0.8300.8300%0.792+5%0.787+5%0.517+60%0.433+92%
Debt To Equity Ratio--4.8724.8720%3.815+28%3.838+27%2.353+107%1.471+231%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--84918924.00084918924.0000%86531832.000-2%84345185.333+1%101061851.600-16%95991893.800-12%
Eps---0.030-0.0300%-0.026-13%-0.031+5%-0.031+5%-0.025-15%
Ev To Ebitda Ratio---7.270-7.2700%-8.718+20%-7.689+6%-9.361+29%-11.208+54%
Ev To Sales Ratio--15.97615.9760%20.394-22%29.878-47%75.219-79%102.442-84%
Free Cash Flow Per Share---0.031-0.0310%0.057-153%0.000-99%-0.009-72%-0.012-61%
Free Cash Flow To Equity Per Share---0.017-0.0170%0.057-130%0.006-394%0.008-324%0.008-326%
Gross Profit Margin--1.4301.4300%1.274+12%1.355+5%1.292+11%1.277+12%
Intrinsic Value_10Y_max---0.012----------
Intrinsic Value_10Y_min---0.187----------
Intrinsic Value_1Y_max---0.001----------
Intrinsic Value_1Y_min---0.014----------
Intrinsic Value_3Y_max---0.002----------
Intrinsic Value_3Y_min---0.046----------
Intrinsic Value_5Y_max---0.005----------
Intrinsic Value_5Y_min---0.083----------
Market Cap307830160.000+72%86387120.00086387120.0000%85170400.000+1%90037280.000-4%98067632.000-12%92835736.000-7%
Net Profit Margin---1.351-1.3510%-1.473+9%-2.923+116%-5.239+288%-5.998+344%
Operating Margin---2.295-2.2950%-2.470+8%-4.172+82%-7.526+228%-8.947+290%
Operating Ratio--3.1983.1980%3.430-7%5.050-37%8.355-62%9.463-66%
Pb Ratio67.915+72%19.05919.0590%13.851+38%14.287+33%11.007+73%15.023+27%
Pe Ratio-42.868-256%-12.030-12.0300%-13.631+13%-12.161+1%-12.967+8%-15.999+33%
Price Per Share1.265+72%0.3550.3550%0.350+1%0.370-4%0.403-12%0.382-7%
Price To Free Cash Flow Ratio-41.335-256%-11.600-11.6000%6.101-290%-6.667-43%-12.841+11%-18.273+58%
Price To Total Gains Ratio-190.444-256%-53.445-53.4450%-22.678-58%-30.088-44%-23.673-56%-48.679-9%
Quick Ratio--4.1024.1020%5.664-28%4.946-17%6.908-41%4.977-18%
Return On Assets---0.270-0.2700%-0.211-22%-0.240-11%-0.291+8%-0.467+73%
Return On Equity---1.584-1.5840%-1.016-36%-1.173-26%-0.870-45%-0.984-38%
Total Gains Per Share---0.007-0.0070%-0.015+132%-0.017+155%-0.005-23%0.002-463%
Usd Book Value--2983340.2072983340.2070%4047240.865-26%4516603.723-34%7683036.828-61%5623761.965-47%
Usd Book Value Change Per Share---0.004-0.0040%-0.010+132%-0.011+155%-0.003-23%0.001-463%
Usd Book Value Per Share--0.0120.0120%0.017-26%0.019-34%0.032-61%0.023-47%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--55893635.77755893635.7770%56955251.822-2%55516000.986+1%66518910.723-16%63181864.499-12%
Usd Eps---0.019-0.0190%-0.017-13%-0.020+5%-0.020+5%-0.017-15%
Usd Free Cash Flow---4901710.181-4901710.1810%9189141.389-153%-62003.976-99%-1371231.483-72%-1921398.286-61%
Usd Free Cash Flow Per Share---0.020-0.0200%0.038-153%0.000-99%-0.006-72%-0.008-61%
Usd Free Cash Flow To Equity Per Share---0.011-0.0110%0.037-130%0.004-394%0.005-324%0.005-326%
Usd Market Cap202613811.312+72%56860002.38456860002.3840%56059157.280+1%59262537.696-4%64548115.382-12%61104481.435-7%
Usd Price Per Share0.833+72%0.2340.2340%0.230+1%0.244-4%0.265-12%0.251-7%
Usd Profit---4726507.214-4726507.2140%-4112552.734-13%-4944338.065+5%-4965958.268+5%-4017527.874-15%
Usd Revenue--3498579.8253498579.8250%2792788.016+25%2433181.543+44%1688631.451+107%1078080.919+225%
Usd Total Gains Per Share---0.004-0.0040%-0.010+132%-0.011+155%-0.003-23%0.001-463%
 EOD+5 -3MRQTTM+0 -0YOY+14 -243Y+17 -215Y+11 -2710Y+8 -30

3.3 Fundamental Score

Let's check the fundamental score of Orthocell Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-42.868
Price to Book Ratio (EOD)Between0-167.915
Net Profit Margin (MRQ)Greater than0-1.351
Operating Margin (MRQ)Greater than0-2.295
Quick Ratio (MRQ)Greater than14.102
Current Ratio (MRQ)Greater than14.336
Debt to Asset Ratio (MRQ)Less than10.830
Debt to Equity Ratio (MRQ)Less than14.872
Return on Equity (MRQ)Greater than0.15-1.584
Return on Assets (MRQ)Greater than0.05-0.270
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Orthocell Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.055
Ma 20Greater thanMa 501.216
Ma 50Greater thanMa 1001.274
Ma 100Greater thanMa 2001.330
OpenGreater thanClose1.250
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Orthocell Ltd

Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia, the United States, the United Kingdom, and the European Union. The company offers Ortho-ATI, a cell therapy for treatment of chronic tendon injuries; Striate+, a resorbable collagen membrane used for guided bone and tissue regeneration in dental procedure; Remplir, a collagen scaffold used in peripheral nerve repair; and Ortho-ACI, an autologous chondrocyte implantation to treat articular cartilage defects in the knee and ankle. Orthocell Limited was incorporated in 2006 and is headquartered in Murdoch, Australia.

Fundamental data was last updated by Penke on 2025-07-09 00:06:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Orthocell earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Orthocell to theΒ Biotechnology industry mean.
  • A Net Profit Margin of -135.1%Β means thatΒ $-1.35 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Orthocell Ltd:

  • The MRQ is -135.1%. The company is making a huge loss. -2
  • The TTM is -135.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-135.1%TTM-135.1%0.0%
TTM-135.1%YOY-147.3%+12.2%
TTM-135.1%5Y-523.9%+388.8%
5Y-523.9%10Y-599.8%+75.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-135.1%-91.7%-43.4%
TTM-135.1%-140.3%+5.2%
YOY-147.3%-196.4%+49.1%
3Y-292.3%-247.9%-44.4%
5Y-523.9%-343.3%-180.6%
10Y-599.8%-488.1%-111.7%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Orthocell is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Orthocell to theΒ Biotechnology industry mean.
  • -27.0% Return on Assets means thatΒ Orthocell generatedΒ $-0.27 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Orthocell Ltd:

  • The MRQ is -27.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -27.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-27.0%TTM-27.0%0.0%
TTM-27.0%YOY-21.1%-5.9%
TTM-27.0%5Y-29.1%+2.1%
5Y-29.1%10Y-46.7%+17.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-27.0%-11.5%-15.5%
TTM-27.0%-11.5%-15.5%
YOY-21.1%-11.4%-9.7%
3Y-24.0%-11.7%-12.3%
5Y-29.1%-11.9%-17.2%
10Y-46.7%-13.7%-33.0%
4.3.1.3. Return on Equity

Shows how efficient Orthocell is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Orthocell to theΒ Biotechnology industry mean.
  • -158.4% Return on Equity means Orthocell generated $-1.58Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Orthocell Ltd:

  • The MRQ is -158.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -158.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-158.4%TTM-158.4%0.0%
TTM-158.4%YOY-101.6%-56.8%
TTM-158.4%5Y-87.0%-71.4%
5Y-87.0%10Y-98.4%+11.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-158.4%-13.6%-144.8%
TTM-158.4%-14.8%-143.6%
YOY-101.6%-14.4%-87.2%
3Y-117.3%-16.8%-100.5%
5Y-87.0%-17.5%-69.5%
10Y-98.4%-19.5%-78.9%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Orthocell Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Orthocell is operatingΒ .

  • Measures how much profit Orthocell makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Orthocell to theΒ Biotechnology industry mean.
  • An Operating Margin of -229.5%Β means the company generated $-2.29 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Orthocell Ltd:

  • The MRQ is -229.5%. The company is operating very inefficient. -2
  • The TTM is -229.5%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-229.5%TTM-229.5%0.0%
TTM-229.5%YOY-247.0%+17.5%
TTM-229.5%5Y-752.6%+523.2%
5Y-752.6%10Y-894.7%+142.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-229.5%-221.8%-7.7%
TTM-229.5%-250.7%+21.2%
YOY-247.0%-208.5%-38.5%
3Y-417.2%-220.2%-197.0%
5Y-752.6%-342.4%-410.2%
10Y-894.7%-462.5%-432.2%
4.3.2.2. Operating Ratio

Measures how efficient Orthocell is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 3.20 means that the operating costs are $3.20 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Orthocell Ltd:

  • The MRQ is 3.198. The company is inefficient in keeping operating costs low. -1
  • The TTM is 3.198. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ3.198TTM3.1980.000
TTM3.198YOY3.430-0.232
TTM3.1985Y8.355-5.157
5Y8.35510Y9.463-1.108
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.1982.097+1.101
TTM3.1982.684+0.514
YOY3.4303.076+0.354
3Y5.0503.524+1.526
5Y8.3554.724+3.631
10Y9.4636.445+3.018
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Orthocell Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Orthocell is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 4.34Β means the company has $4.34 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Orthocell Ltd:

  • The MRQ is 4.336. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.336. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.336TTM4.3360.000
TTM4.336YOY5.930-1.594
TTM4.3365Y7.090-2.754
5Y7.09010Y5.126+1.964
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.3363.638+0.698
TTM4.3363.846+0.490
YOY5.9304.140+1.790
3Y5.1464.688+0.458
5Y7.0905.722+1.368
10Y5.1266.144-1.018
4.4.3.2. Quick Ratio

Measures if Orthocell is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Orthocell to theΒ Biotechnology industry mean.
  • A Quick Ratio of 4.10Β means the company can pay off $4.10 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Orthocell Ltd:

  • The MRQ is 4.102. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.102. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.102TTM4.1020.000
TTM4.102YOY5.664-1.562
TTM4.1025Y6.908-2.806
5Y6.90810Y4.977+1.931
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.1022.826+1.276
TTM4.1023.116+0.986
YOY5.6643.786+1.878
3Y4.9464.311+0.635
5Y6.9085.702+1.206
10Y4.9776.335-1.358
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Orthocell Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of OrthocellΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Orthocell to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.83Β means that Orthocell assets areΒ financed with 83.0% credit (debt) and the remaining percentage (100% - 83.0%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Orthocell Ltd:

  • The MRQ is 0.830. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.830. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.830TTM0.8300.000
TTM0.830YOY0.792+0.037
TTM0.8305Y0.517+0.313
5Y0.51710Y0.433+0.084
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8300.327+0.503
TTM0.8300.349+0.481
YOY0.7920.332+0.460
3Y0.7870.340+0.447
5Y0.5170.346+0.171
10Y0.4330.378+0.055
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Orthocell is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Orthocell to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 487.2% means that company has $4.87 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Orthocell Ltd:

  • The MRQ is 4.872. The company is unable to pay all its debts with equity. -1
  • The TTM is 4.872. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ4.872TTM4.8720.000
TTM4.872YOY3.815+1.057
TTM4.8725Y2.353+2.519
5Y2.35310Y1.471+0.883
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.8720.383+4.489
TTM4.8720.438+4.434
YOY3.8150.414+3.401
3Y3.8380.450+3.388
5Y2.3530.457+1.896
10Y1.4710.512+0.959
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Orthocell generates.

  • Above 15 is considered overpriced butΒ always compareΒ Orthocell to theΒ Biotechnology industry mean.
  • A PE ratio of -12.03 means the investor is paying $-12.03Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Orthocell Ltd:

  • The EOD is -42.868. Based on the earnings, the company is expensive. -2
  • The MRQ is -12.030. Based on the earnings, the company is expensive. -2
  • The TTM is -12.030. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-42.868MRQ-12.030-30.838
MRQ-12.030TTM-12.0300.000
TTM-12.030YOY-13.631+1.601
TTM-12.0305Y-12.967+0.937
5Y-12.96710Y-15.999+3.032
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-42.868-2.399-40.469
MRQ-12.030-2.092-9.938
TTM-12.030-2.625-9.405
YOY-13.631-3.784-9.847
3Y-12.161-3.762-8.399
5Y-12.967-6.363-6.604
10Y-15.999-7.055-8.944
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Orthocell Ltd:

  • The EOD is -41.335. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -11.600. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -11.600. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-41.335MRQ-11.600-29.735
MRQ-11.600TTM-11.6000.000
TTM-11.600YOY6.101-17.701
TTM-11.6005Y-12.841+1.241
5Y-12.84110Y-18.273+5.432
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-41.335-3.299-38.036
MRQ-11.600-2.742-8.858
TTM-11.600-3.801-7.799
YOY6.101-4.402+10.503
3Y-6.667-5.140-1.527
5Y-12.841-8.483-4.358
10Y-18.273-9.296-8.977
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Orthocell is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of 19.06 means the investor is paying $19.06Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Orthocell Ltd:

  • The EOD is 67.915. Based on the equity, the company is expensive. -2
  • The MRQ is 19.059. Based on the equity, the company is expensive. -2
  • The TTM is 19.059. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD67.915MRQ19.059+48.856
MRQ19.059TTM19.0590.000
TTM19.059YOY13.851+5.208
TTM19.0595Y11.007+8.052
5Y11.00710Y15.023-4.016
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD67.9152.113+65.802
MRQ19.0591.856+17.203
TTM19.0592.125+16.934
YOY13.8512.454+11.397
3Y14.2872.492+11.795
5Y11.0073.668+7.339
10Y15.0234.364+10.659
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Orthocell Ltd.

3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2020-06-302021-06-302022-06-302023-06-302024-06-30
Long-term Assets Other  -2,365107-2,258-374-2,632-107-2,7393,7851,046



5.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets26,615
Total Liabilities22,083
Total Stockholder Equity4,533
 As reported
Total Liabilities 22,083
Total Stockholder Equity+ 4,533
Total Assets = 26,615

Assets

Total Assets26,615
Total Current Assets23,007
Long-term Assets3,608
Total Current Assets
Cash And Cash Equivalents 20,614
Net Receivables 1,152
Inventory 1,177
Other Current Assets 64
Total Current Assets  (as reported)23,007
Total Current Assets  (calculated)23,007
+/-0
Long-term Assets
Property Plant Equipment 2,562
Intangible Assets 1,046
Long-term Assets  (as reported)3,608
Long-term Assets  (calculated)3,608
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities5,306
Long-term Liabilities16,777
Total Stockholder Equity4,533
Total Current Liabilities
Short-term Debt 149
Accounts payable 1,354
Other Current Liabilities 1,499
Total Current Liabilities  (as reported)5,306
Total Current Liabilities  (calculated)3,002
+/- 2,304
Long-term Liabilities
Capital Lease Obligations 690
Long-term Liabilities  (as reported)16,777
Long-term Liabilities  (calculated)690
+/- 16,087
Total Stockholder Equity
Common Stock62,220
Retained Earnings -65,626
Accumulated Other Comprehensive Income 7,939
Total Stockholder Equity (as reported)4,533
Total Stockholder Equity (calculated)4,533
+/-0
Other
Capital Stock62,220
Cash and Short Term Investments 20,614
Common Stock Shares Outstanding 202,008
Current Deferred Revenue2,304
Liabilities and Stockholders Equity 26,615
Net Debt -19,925
Net Invested Capital 4,533
Net Working Capital 17,701
Property Plant and Equipment Gross 3,816
Short Long Term Debt Total 690



5.3. Balance Sheets Structured

Currency in AUD. All numbers in thousands.

 Trend2024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302011-06-302010-06-30
> Total Assets 
1,517
1,909
1,765
5,138
6,536
7,113
7,159
5,230
13,598
23,171
19,330
37,896
29,605
26,615
26,61529,60537,89619,33023,17113,5985,2307,1597,1136,5365,1381,7651,9091,517
   > Total Current Assets 
0
0
924
4,051
5,185
5,560
5,285
3,229
11,528
20,805
17,072
35,264
26,866
23,007
23,00726,86635,26417,07220,80511,5283,2295,2855,5605,1854,05192400
       Cash And Cash Equivalents 
212
559
591
3,467
4,774
5,182
5,046
2,910
11,236
20,442
16,329
11,022
24,818
20,614
20,61424,81811,02216,32920,44211,2362,9105,0465,1824,7743,467591559212
       Net Receivables 
613
563
131
113
222
126
36
111
75
253
264
23,547
843
1,152
1,15284323,5472642537511136126222113131563613
       Other Current Assets 
11
10
18
319
39
118
115
154
162
63
11
82
171
64
6417182116316215411511839319181011
   > Long-term Assets 
0
0
841
1,087
1,351
1,553
1,874
2,001
2,070
2,365
2,258
2,632
2,739
3,608
3,6082,7392,6322,2582,3652,0702,0011,8741,5531,3511,08784100
       Property Plant Equipment 
376
348
303
287
306
289
358
341
287
736
934
1,402
1,606
2,562
2,5621,6061,402934736287341358289306287303348376
       Intangible Assets 
197
281
538
800
1,045
1,264
1,516
1,660
1,782
1,630
1,324
1,230
1,133
1,046
1,0461,1331,2301,3241,6301,7821,6601,5161,2641,045800538281197
       Long-term Assets Other 
0
0
-841
-1,087
-1,351
-1,553
-1,874
-2,001
-2,070
-2,365
-2,258
-2,632
-2,739
1,046
1,046-2,739-2,632-2,258-2,365-2,070-2,001-1,874-1,553-1,351-1,087-84100
> Total Liabilities 
205
343
687
5,062
2,152
2,229
2,446
2,858
2,873
2,267
2,456
27,991
23,457
22,083
22,08323,45727,9912,4562,2672,8732,8582,4462,2292,1525,062687343205
   > Total Current Liabilities 
205
343
687
4,306
1,302
1,520
1,880
2,433
2,859
1,861
1,934
6,818
4,530
5,306
5,3064,5306,8181,9341,8612,8592,4331,8801,5201,3024,306687343205
       Short-term Debt 
0
0
0
108
142
142
142
142
108
108
114
120
181
149
149181120114108108142142142142108000
       Accounts payable 
101
145
278
711
629
649
891
1,020
1,649
790
893
3,282
876
1,354
1,3548763,2828937901,6491,020891649629711278145101
       Other Current Liabilities 
104
198
409
3,487
531
730
847
1,412
1,224
963
927
3,415
1,170
1,499
1,4991,1703,4159279631,2241,4128477305313,487409198104
   > Long-term Liabilities 
0
0
0
756
850
709
567
425
406
406
522
21,173
18,926
16,777
16,77718,92621,173522406406425567709850756000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
393
508
388
382
0
0382388508393000000000
       Other Liabilities 
0
0
864
756
850
709
567
425
14
13
15
20,786
18,545
0
018,54520,78615131442556770985075686400
> Total Stockholder Equity
1,312
1,566
214
76
4,384
4,885
4,712
2,372
10,724
20,903
16,874
9,905
6,149
4,533
4,5336,1499,90516,87420,90310,7242,3724,7124,8854,384762141,5661,312
   Common Stock
1,914
3,090
3,163
3,313
16,237
20,664
24,664
27,622
41,447
53,675
55,776
57,476
57,898
62,220
62,22057,89857,47655,77653,67541,44727,62224,66420,66416,2373,3133,1633,0901,914
   Retained Earnings Total Equity00000000000000
   Accumulated Other Comprehensive Income 
0
0
85
1,078
798
1,027
1,289
1,026
1,955
3,376
6,213
5,914
7,335
7,939
7,9397,3355,9146,2133,3761,9551,0261,2891,0277981,0788500
   Capital Surplus 00000000000000
   Treasury Stock00000000000000
   Other Stockholders Equity 
0
0
85
0
-935
-1,304
-1,561
-1,637
-2,420
-20,608
-13,741
-7,070
-1,893
0
0-1,893-7,070-13,741-20,608-2,420-1,637-1,561-1,304-93508500



5.4. Balance Sheets

Currency in AUD. All numbers in thousands.




5.5. Cash Flows

Currency in AUD. All numbers in thousands.




5.6. Income Statements

Currency in AUD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2024-06-30. Currency in AUD. All numbers in thousands.

Gross Profit (+$)
totalRevenue5,315
Cost of Revenue-1,627
Gross Profit3,6883,688
 
Operating Income (+$)
Gross Profit3,688
Operating Expense-15,370
Operating Income-11,681-11,681
 
Operating Expense (+$)
Research Development8,674
Selling General Administrative3,610
Selling And Marketing Expenses3,085
Operating Expense15,37015,370
 
Net Interest Income (+$)
Interest Income1,032
Interest Expense-61
Other Finance Cost-0
Net Interest Income971
 
Pretax Income (+$)
Operating Income-11,681
Net Interest Income971
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-10,232-13,130
EBIT - interestExpense = -12,259
-10,232
-7,120
Interest Expense61
Earnings Before Interest and Taxes (EBIT)-12,198-10,172
Earnings Before Interest and Taxes (EBITDA)-11,681
 
After tax Income (+$)
Income Before Tax-10,232
Tax Provision--3,051
Net Income From Continuing Ops-7,181-7,181
Net Income-7,181
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses16,996
Total Other Income/Expenses Net1,449-971
 

Technical Analysis of Orthocell
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Orthocell. The general trend of Orthocell is NEUTRAL with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Orthocell's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (0.0%) Bearish trend (0.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Orthocell Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Orthocell Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.37 < 1.7 < 1.79.

The bearish price targets are: 1.055 > 0.765 > 0.745.

Know someone who trades $OCC? Share this with them.πŸ‘‡

Orthocell Ltd Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Orthocell Ltd. The current mas is .

The long score for the Moving Averages is 7/14.
The longshort score for the Moving Averages is 0/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Orthocell Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Orthocell Ltd. The current macd is 0.00063195.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Orthocell price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Orthocell. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Orthocell price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Orthocell Ltd Daily Moving Average Convergence/Divergence (MACD) ChartOrthocell Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Orthocell Ltd. The current adx is 15.23.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Orthocell shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Orthocell Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Orthocell Ltd. The current sar is 1.1343095.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Orthocell Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Orthocell Ltd. The current rsi is 52.06. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Orthocell Ltd Daily Relative Strength Index (RSI) ChartOrthocell Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Orthocell Ltd. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Orthocell price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Orthocell Ltd Daily Stochastic Oscillator ChartOrthocell Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Orthocell Ltd. The current cci is 57.12.

Orthocell Ltd Daily Commodity Channel Index (CCI) ChartOrthocell Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Orthocell Ltd. The current cmo is 7.74195777.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Orthocell Ltd Daily Chande Momentum Oscillator (CMO) ChartOrthocell Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Orthocell Ltd. The current willr is -33.33333333.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Orthocell is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Orthocell Ltd Daily Williams %R ChartOrthocell Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Orthocell Ltd.

Orthocell Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Orthocell Ltd. The current atr is 0.07285523.

Orthocell Ltd Daily Average True Range (ATR) ChartOrthocell Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Orthocell Ltd. The current obv is 3,506,700.

Orthocell Ltd Daily On-Balance Volume (OBV) ChartOrthocell Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Orthocell Ltd. The current mfi is 59.30.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Orthocell Ltd Daily Money Flow Index (MFI) ChartOrthocell Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Orthocell Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-24BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-25MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-27MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-02-28STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-03STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-04STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-03-24BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-31STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-04-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-04-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-30CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-01STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-02STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-05-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-05-14WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-21STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-05-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-30STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-06-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-06-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-06-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-06-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-23BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-06-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-04STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-10STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Orthocell Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Orthocell Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.055
Ma 20Greater thanMa 501.216
Ma 50Greater thanMa 1001.274
Ma 100Greater thanMa 2001.330
OpenGreater thanClose1.250
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Orthocell with someone you think should read this too:
  • Are you bullish or bearish on Orthocell? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Orthocell? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Orthocell Ltd

I send you an email if I find something interesting about Orthocell Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Orthocell Ltd.

Receive notifications about Orthocell Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.